{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:50:08Z","timestamp":1761519008766},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.ejim.2011.03.009","type":"journal-article","created":{"date-parts":[[2011,4,18]],"date-time":"2011-04-18T22:18:15Z","timestamp":1303165095000},"page":"330-333","source":"Crossref","is-referenced-by-count":18,"title":["Should we treat mild subclinical\/mild hyperthyroidism? No"],"prefix":"10.1016","volume":"22","author":[{"given":"Mark P.J.","family":"Vanderpump","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2011.03.009_bb0005","series-title":"Werner and Ingbar's the thyroid: a fundamental and clinical text","first-page":"398","article-title":"The epidemiology of thyroid diseases","author":"Vanderpump","year":"2005"},{"key":"10.1016\/j.ejim.2011.03.009_bb0010","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1210\/er.2006-0043","article-title":"The clinical significance of subclinical thyroid dysfunction","volume":"29","author":"Biondi","year":"2008","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ejim.2011.03.009_bb0015","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/archinte.160.4.526","article-title":"The Colorado thyroid disease prevalence study","volume":"160","author":"Canaris","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejim.2011.03.009_bb0020","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1210\/jc.87.2.489","article-title":"Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)","volume":"87","author":"Hollowell","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2011.03.009_bb0025","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/archinte.1991.00400010159025","article-title":"Low serum thyrotropin (thyroid-stimulating hormone) in older persons without hyperthyroidism","volume":"151","author":"Sawin","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejim.2011.03.009_bb0030","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/archinte.162.7.773","article-title":"Association between thyroid dysfunction and total cholesterol level in an older biracial population. The health, aging and body composition study","volume":"162","author":"Kanaya","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejim.2011.03.009_bb0035","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1001\/jama.292.21.2591","article-title":"Thyroid status, disability and cognitive function, and survival in old age","volume":"292","author":"Gussekloo","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2011.03.009_bb0040","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1210\/jc.84.2.561","article-title":"The spectrum of thyroid disorders in an iodine-deficient community: the Pescopagano survey","volume":"84","author":"Aghini-Lombardi","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2011.03.009_bb0045","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1089\/105072501300176417","article-title":"Environmental iodine intake affects the type of non-malignant thyroid disease","volume":"11","author":"Laurberg","year":"2001","journal-title":"Thyroid"},{"year":"2002","series-title":"Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease","key":"10.1016\/j.ejim.2011.03.009_bb0050"},{"year":"2006","series-title":"UK guidelines for the use of thyroid function tests","author":"Association of Clinical Biochemistry, British Thyroid Association and British Thyroid Foundation","key":"10.1016\/j.ejim.2011.03.009_bb0055"},{"key":"10.1016\/j.ejim.2011.03.009_bb0060","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.1210\/jc.86.10.4591","article-title":"The treatment of subclinical hypothyroidism is seldom necessary","volume":"86","author":"Chu","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2011.03.009_bb0065","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2265.1991.tb01739.x","article-title":"Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom","volume":"34","author":"Parle","year":"1991","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ejim.2011.03.009_bb0070","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1365-2265.2009.03696.x","article-title":"The natural history of subclinical hyperthyroidism in elderly patients with TSH between 0.1 and 0.4mU\/L: a prospective study","volume":"72","author":"Rosario","year":"2010","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ejim.2011.03.009_bb0075","article-title":"The thyroid epidemiology, audit, and research study (TEARS): the natural history of endogenous subclinical hyperthyroidism","author":"Vadiveloo","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2011.03.009_bb0080","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1001\/archinte.159.7.658","article-title":"Diagnosis of thyroid disease in hospitalized patients. A systematic review","volume":"159","author":"Attia","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejim.2011.03.009_bb0085","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1532-5415.1996.tb01445.x","article-title":"Low TSH levels in nursing home residents not taking thyroid hormone","volume":"44","author":"Drinka","year":"1996","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.ejim.2011.03.009_bb0090","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0140-6736(01)06067-6","article-title":"Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study","volume":"358","author":"Parle","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2011.03.009_bb0095","doi-asserted-by":"crossref","first-page":"832","DOI":"10.7326\/0003-4819-148-11-200806030-00225","article-title":"Meta-analysis: subclinical thyroid dysfunction and the risk of coronary heart disease and mortality","volume":"148","author":"Ochs","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2011.03.009_bb0100","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJM199411103311901","article-title":"Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons","volume":"331","author":"Sawin","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2011.03.009_bb0105","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.295.9.1033","article-title":"Thyroid status, cardiovascular risk and mortality in older adults","volume":"295","author":"Cappola","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2011.03.009_bb0110","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1089\/thy.2009.0272","article-title":"Thyroid function and left ventricular structure and function in the Framingham Heart Study","volume":"20","author":"Pearce","year":"2010","journal-title":"Thyroid"},{"key":"10.1016\/j.ejim.2011.03.009_bb0115","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2265.2010.03882.x","article-title":"Subclinical hyperthyroidism is not associated with progression of cardiac mass and development of left ventricular hypertrophy in middle-aged and older subjects. Results from a five-year follow-up","author":"D\u00f6rr","year":"2010","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ejim.2011.03.009_bb0120","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1210\/jc.82.9.2931","article-title":"Low thyrotropin levels are not associated with bone loss in older women: a prospective study","volume":"82","author":"Bauer","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2011.03.009_bb0125","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1056\/NEJM199503233321202","article-title":"Risk factors for hip fracture in white women","volume":"332","author":"Cummings","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2011.03.009_bb0130","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1210\/jc.81.12.4278","article-title":"Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis","volume":"81","author":"Uzzan","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2011.03.009_bb0135","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1530\/eje.0.1300350","article-title":"Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis","volume":"130","author":"Faber","year":"1994","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ejim.2011.03.009_bb0140","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0300-2977(94)00089-R","article-title":"Subclinical hypothyroidism and hyperthyroidism. I. Prevalence and incidence","volume":"46","author":"Wiersinga","year":"1995","journal-title":"Neth J Med"},{"key":"10.1016\/j.ejim.2011.03.009_bb0145","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1046\/j.1365-2265.2000.01146.x","article-title":"Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study","volume":"53","author":"Kalmijn","year":"2000","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ejim.2011.03.009_bb0150","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1365-2265.2009.03694.x","article-title":"How should we treat patients with low serum thyrotrophin concentrations?","volume":"72","author":"Mitchell","year":"2010","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ejim.2011.03.009_bb0155","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-2265.2004.02135.x","article-title":"Spontanoeus reporting of adverse reaction to carbimazole and propythiouracil in the United Kingdom","volume":"61","author":"Pearce","year":"2004","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ejim.2011.03.009_bb0160","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/BF02598988","article-title":"Does treatment with L-thyroxine influence health status in middle-aged and older adults with subclinical hypothyroidism?","volume":"11","author":"Jaeschke","year":"1996","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.ejim.2011.03.009_bb0165","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0002-9343(02)01022-7","article-title":"A 6-month randomized trial of thyroxine treatment in women with mild subclinical hypothyroidism","volume":"112","author":"Kong","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.ejim.2011.03.009_bb0170","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-2265.1988.tb00250.x","article-title":"A double-blind cross-over 12-month study of L-thyroxine treatment of women with \u2018subclinical\u2019 hypothyroidism","volume":"29","author":"Nystrom","year":"1988","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ejim.2011.03.009_bb0175","doi-asserted-by":"crossref","first-page":"750","DOI":"10.7326\/0003-4819-130-9-199905040-00016","article-title":"The effect of thyroid hormone on skeletal integrity","volume":"130","author":"Greenspan","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2011.03.009_bb0180","first-page":"107","article-title":"Thyroxine prescription in the community: serum thyroid stimulating hormone level assays as an indicator of undertreatment or overtreatment","volume":"43","author":"Parle","year":"1993","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.ejim.2011.03.009_bb0185","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1001\/jama.291.2.228","article-title":"Subclinical thyroid disease. Scientific review and guidelines for diagnosis and management","volume":"291","author":"Surks","year":"2004","journal-title":"JAMA"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620511000653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620511000653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T11:55:21Z","timestamp":1543838121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620511000653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0953620511000653"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2011.03.009","relation":{},"ISSN":["0953-6205"],"issn-type":[{"type":"print","value":"0953-6205"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}